Follow
Dr Wei Cope
Dr Wei Cope
Verified email at nhs.net
Title
Cited by
Cited by
Year
Multi-omic machine learning predictor of breast cancer therapy response
SJ Sammut, M Crispin-Ortuzar, SF Chin, E Provenzano, HA Bardwell, ...
Nature 601 (7894), 623-629, 2022
2402022
The genomic and immune landscapes of lethal metastatic breast cancer
L De Mattos-Arruda, SJ Sammut, EM Ross, R Bashford-Rogers, ...
Cell reports 27 (9), 2690-2708. e10, 2019
1072019
Auditory temporal-envelope processing in high-functioning children with autism spectrum disorder
JI Alcántara, TE Cope, W Cope, EJ Weisblatt
Neuropsychologia 50 (7), 1235-1251, 2012
612012
Effects of level and frequency on the audibility of partials in inharmonic complex tones
BCJ Moore, BR Glasberg, KE Low, T Cope, W Cope
The Journal of the Acoustical Society of America 120 (2), 934-944, 2006
472006
The association of warthin tumor with salivary ductal inclusions in intra and periparotid lymph nodes
W Cope, C Naugler, SM Taylor, J Trites, RD Hart, MJ Bullock
Head and neck pathology 8, 73-76, 2014
302014
miR-146a and miR-155 expression levels in acute graft-versus-host disease incidence
S Atarod, MM Ahmed, C Lendrem, KF Pearce, W Cope, J Norden, ...
Frontiers in immunology 7, 56, 2016
292016
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants
M Messaoudene, TP Mourikis, J Michels, Y Fu, M Bonvalet, ...
Annals of Oncology 30 (6), 934-944, 2019
252019
The mechanism of balloon Eustachian tuboplasty: a biomechanical study
ME Smith, AE Weir, DCC Prior, W Cope, JR Tysome, M Sutcliffe
Medical & Biological Engineering & Computing 58, 689-699, 2020
182020
A case of necrotising fasciitis caused by Serratia marsescens: extreme age as functional immunosuppression?
TE Cope, W Cope, DM Beaumont
Age and ageing 42 (2), 266-268, 2013
142013
Effect of provision of the NHS NPSA oral anticoagulant therapy patient information pack upon patients’ knowledge and anticoagulant control
L Fairbairn‐Smith, W Cope, B Robinson, F Kamali, H Wynne
Journal of Thrombosis and Haemostasis 9 (1), 231-233, 2011
72011
The diagnosis and management of lobular carcinoma in situ
W Cope, E Provenzano
Diagnostic Histopathology 29 (3), 153-161, 2023
22023
Prevalence of Salivary Ductal Inclusions in Parotid Lymph Nodes of Patients with Warthin Tumor
W Cope, CT Naugler, T Vyas, MJ Bullock
LABORATORY INVESTIGATION 89, 247A-247A, 2009
12009
Expression of transglutaminase-2 (TGM2) in the prognosis of female invasive breast cancer
FM Blows, HR Ali, W Cope, PDP Pharoah, CVS Pike, E Provenzano, ...
BJC Reports 2 (1), 5, 2024
2024
Predicting response to treatment in early breast cancer using dynamic integrative multi-omic profiling
SJ Sammut, M Crispin-Ortuzar, SF Chin, E Provenzano, W Cope, ...
Cancer Research 82 (12_Supplement), 476-476, 2022
2022
Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer with Gene Expression and Computational Pathology
W Cope
2022
Investigation of transglutaminase 2 as a biomarker of invasive breast cancer that is likely to metastasise
F Blows, E Provenzano, R Ali, W Cope, P Pharoah, C Pike, P Coussons
BRITISH JOURNAL OF CANCER 119 (11), 31-31, 2018
2018
MiR-146a and miR-155 expression levels in allogeneic haematopoietic stem cell transplantation patients is predictive of acute graft-versus-host incidence
S Atarod, M Ahmed, C Lendrem, K Pearce, W Cope, J Norden, X Wang, ...
41st Annual Meeting of the European Society for Blood and Marrow Transplantation, 2015
2015
MiR-146a-5p and its targets in graft-versus-host disease
S Atarod, W Cope, J Norden, M Collin, X Wang, A Dickinson
BONE MARROW TRANSPLANTATION, 2013
2013
miR-146a expression in graft-versus-host disease
S Atarod, W Cope, J Norden, M Collin, AM Dickinson
38th Annual Meeting of the European Group for Blood and Marrow …, 2012
2012
Role of miR-146a-5p in Graft-versus-Host Disease
S Atarod, W Cope, J Norden, M Collin, AM Dickinson
European Congress of Immunology, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–20